-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BbeG+nm0B762FqLf4USHTulYvaIOtJgnpqhcZfwNl7/5rq73FcW/teWAuaSKATMI aka/Zi1tc4LQV2hXbncJdA== 0001072613-10-000092.txt : 20100205 0001072613-10-000092.hdr.sgml : 20100205 20100205152803 ACCESSION NUMBER: 0001072613-10-000092 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100205 DATE AS OF CHANGE: 20100205 GROUP MEMBERS: C. RICHARD KRAMLICH GROUP MEMBERS: CHARLES M. LINEHAN GROUP MEMBERS: CHARLES W. NEWHALL III GROUP MEMBERS: EUGENE A. TRAINOR III GROUP MEMBERS: FOREST BASKETT GROUP MEMBERS: KRISHNA S. KOLLURI GROUP MEMBERS: M. JAMES BARRETT GROUP MEMBERS: MARK W. PERRY GROUP MEMBERS: NEA 12 GP, LLC GROUP MEMBERS: NEA PARTNERS 12, LIMITED PARTNERSHIP GROUP MEMBERS: NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP GROUP MEMBERS: PATRICK J. KERINS GROUP MEMBERS: PETER J. BARRIS GROUP MEMBERS: RYAN D. DRANT GROUP MEMBERS: SCOTT D. SANDELL SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: REPROS THERAPEUTICS INC. CENTRAL INDEX KEY: 0000897075 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 760233274 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-52909 FILM NUMBER: 10577301 BUSINESS ADDRESS: STREET 1: 2408 TIMBERLOCH PL STREET 2: SUITE B-7 CITY: WOODLANDS STATE: TX ZIP: 77380 BUSINESS PHONE: 2817193400 MAIL ADDRESS: STREET 1: 2408 TIMBERLOCH PLACE B-7 CITY: THE WOODLANDS STATE: TX ZIP: 77380 FORMER COMPANY: FORMER CONFORMED NAME: REPROS THERAPEUTICS INC DATE OF NAME CHANGE: 20060503 FORMER COMPANY: FORMER CONFORMED NAME: ZONAGEN INC DATE OF NAME CHANGE: 19930208 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Growth Equity Opportunities Fund, LLC CENTRAL INDEX KEY: 0001448784 IRS NUMBER: 204670653 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1119 ST. PAUL STREET CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-244-0115 MAIL ADDRESS: STREET 1: 1119 ST. PAUL STREET CITY: BALTIMORE STATE: MD ZIP: 21202 SC 13G/A 1 repros-sch13ga_16682.htm GROWT EQUITY OPPORTUNITIES FUND, LLC WWW.EXFILE.COM, INC. -- 888-775-4789 -- GROWTH EQUITY OPPROTUNITIES FUND, LLC -- SCHEDULE 13-GA


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

______________

SCHEDULE 13G
 
 
Under the Securities Exchange Act of 1934

(Amendment No. 1)*


Repros Therapeutics Inc.

(Name of Issuer)


Common Stock, $.001 par value per share

(Title of Class of Securities)


76028H100

(CUSIP Number)


December 31, 2009

(Date of Event Which Requires Filing of this Statement)
 
 
 
 

 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o   Rule 13d-1(b)
x   Rule 13d-1(c)


*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 


 
 
  CUSIP No.    76028H100
 
13G
Page 2 of 6
 
Schedule 13G

Item 1(a). 
Name of Issuer:

Repros Therapeutics Inc.

Item 1(b). 
Address of Issuer’s Principal Executive Offices:

2408 Timberloch Place, Suite B-7, The Woodlands, Texas 77380

Item 2(a).
Names of Persons Filing:

Growth Equity Opportunities Fund, LLC (“GEO”); New Enterprise Associates 12, Limited Partnership (“NEA 12”), which is the sole member of GEO; NEA Partners 12, Limited Partnership (“NEA Partners 12”), which is the sole general partner of NEA 12; NEA 12 GP, LLC (“NEA 12 GP”), which is the sole general partner of NEA Partners 12; and M. James Barrett (“Barrett”), Peter J. Barris (“Barris”), Forest Baskett (“Baskett”), Ryan D. Drant (“Drant”), Patrick J. Kerins (“Kerins”), Krishna S. Kolluri (“Kolluri”), C. Richard Kramlich (“Kramlich”), Charles M. Linehan (“Linehan”), Charles W. Newhall III (“Newhall”), Mark W. Perry (“Perry”), Scott D. Sandell (“Sandell”) and Eugene A. Trainor III (“Trainor”) (collectively, the “Managers”).  The Managers are the individual managers of NEA 12 GP.  GEO, NEA 12, NEA Partners 12, NEA 12 GP and the Managers are sometimes referred to collectively herein as the “Reporting Persons.”

Item 2(b). 
Address of Principal Business Office or, if None, Residence:

The address of the principal business office of GEO, NEA 12, NEA Partners 12, NEA 12 GP, Newhall and Trainor is New Enterprise Associates, 1954 Greenspring Drive, Suite 600, Timonium, MD 21093.  The address of the principal business office of Baskett, Kolluri, Kramlich, Linehan, Perry and Sandell is New Enterprise Associates, 2855 Sand Hill Road, Menlo Park, California 94025.  The address of the principal business office of Barrett, Barris, Drant and Kerins is New Enterprise Associates, 5425 Wisconsin Avenue, Suite 800, Chevy Chase, MD 20815.

Item 2(c).
Citizenship:

Each of GEO and NEA 12 GP is a limited liability company organized under the laws of the State of Delaware.  Each of NEA 12 and NEA Partners 12 is a limited partnership organized under the laws of the State of Delaware.  Each of the Managers is a United States citizen.

Item 2(d).
Title of Class of Securities:

Common Stock, $.001 par value (“Common Stock”).

Item 2(e).
CUSIP Number:

76028H100
 
Item 5. 
Ownership of Five Percent or Less of a Class.

Each Reporting Person has ceased to beneficially own five percent or more of the Issuer’s outstanding Common Stock.
 

 
 
 
  CUSIP No.    76028H100
 
13G
Page 3 of 6
 
SIGNATURE

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Date:       February 5, 2010

GROWTH EQUITY OPPORTUNITIES FUND, LLC

By: 
NEW ENTERPRISE ASSOCIATES 12,  LIMITED PARTNERSHIP
Sole Member

By:
NEA PARTNERS 12, LIMITED PARTNERSHIP
General Partner
 
 
By:
NEA 12 GP, LLC
 
General Partner

By: 
                  *
Eugene A. Trainor III
Administrative Manager

NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

By:
NEA PARTNERS 12, LIMITED PARTNERSHIP
 
General Partner

By:
NEA 12 GP, LLC
General Partner
 
By: 
                  *
Eugene A. Trainor III
Administrative Manager
 
NEA PARTNERS 12, LIMITED PARTNERSHIP

By:
NEA 12 GP, LLC
General Partner
 
By: 
                   *
Eugene A. Trainor III
Administrative Manager
 
NEA 12 GP, LLC

By: 
                   *
Eugene A. Trainor III
Administrative Manager
 
         *
M. James Barrett
 
 
 

 
 
  CUSIP No.    76028H100
 
13G
Page 4 of 6
 
         *
Peter J. Barris
 
 
         *
Forest Baskett
 
 
         *
Ryan D. Drant
 
 
         *
Patrick J. Kerins
 
 
         *
Krishna S. Kolluri
 
 
         *
C. Richard Kramlich
 
 
         *
Charles M. Linehan
 
 
        *
Charles W. Newhall III
 
 
         *
Mark W. Perry
 
 
         *
Scott D. Sandell
 
 
         *
Eugene A. Trainor III
 
 
 
*By: /s/ Shawn Conway

Shawn Conway
As attorney-in-fact

This Amendment No. 1 to Schedule 13G was executed by Shawn Conway on behalf of the individuals listed above pursuant to a Power of Attorney which was filed with the Securities and Exchange Commission on March 27, 2009 in connection with the Schedule 13G filing for Repros Therapeutics Inc., which Power of Attorney is incorporated herein by reference.
 

 
 
  CUSIP No.    76028H100
 
13G
Page 5 of 6
 
EXHIBIT 1
 
AGREEMENT

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of stock of Repros Therapeutics Inc.

EXECUTED this 5th day of February, 2010

GROWTH EQUITY OPPORTUNITIES FUND, LLC

By: 
NEW ENTERPRISE ASSOCIATES 12,  LIMITED PARTNERSHIP
Sole Member

By:
NEA PARTNERS 12, LIMITED PARTNERSHIP
General Partner
 
 
By:
NEA 12 GP, LLC
 
General Partner

By: 
                  *
Eugene A. Trainor III
Administrative Manager

NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

By:
NEA PARTNERS 12, LIMITED PARTNERSHIP
 
General Partner

By:
NEA 12 GP, LLC
General Partner
 
By: 
                  *
Eugene A. Trainor III
Administrative Manager
 
NEA PARTNERS 12, LIMITED PARTNERSHIP

By:
NEA 12 GP, LLC
General Partner
 
By: 
                   *
Eugene A. Trainor III
Administrative Manager
 
NEA 12 GP, LLC

By: 
                   *
Eugene A. Trainor III
Administrative Manager
 

 
 
  CUSIP No.    76028H100
 
13G
Page 6 of 6
 
         *
M. James Barrett
 
 
         *
Peter J. Barris
 
 
         *
Forest Baskett
 
 
         *
Ryan D. Drant
 
 
         *
Patrick J. Kerins
 
 
         *
Krishna S. Kolluri
 
 
         *
C. Richard Kramlich
 
 
         *
Charles M. Linehan
 
 
        *
Charles W. Newhall III
 
 
         *
Mark W. Perry
 
 
         *
Scott D. Sandell
 
 
         *
Eugene A. Trainor III
 
 
 
*By: /s/ Shawn Conway

Shawn Conway
As attorney-in-fact
 
This Agreement was executed by Shawn Conway on behalf of the individuals listed above pursuant to a Power of Attorney which was filed with the Securities and Exchange Commission on March 27, 2009 in connection with the Schedule 13G filing for Repros Therapeutics Inc., which Power of Attorney is incorporated herein by reference.
 

 
-----END PRIVACY-ENHANCED MESSAGE-----